Logo
x

Search

Subscribe Now

 P-II

Ipsen Reports P-II (ELMWOOD) Trial Data of Elafibranor for Primary Sclerosing Cholangitis (PSC)

Ipsen Reports P-II (ELMWOOD) Trial Data of Elafibranor for Primary Sclerosing Cholangitis (PSC)

  • April 24, 2025
HUTCHMED Reports Enrollment Completion in P-II Trial of Savolitinib for Gastric Cancer in China

HUTCHMED Reports Enrollment Completion in P-II Trial of Savolitinib for Gastric Cancer in China

  • April 22, 2025
BriaCell Reveals P-II Trial Data of Bria-IMT Regimen for Metastatic Breast Cancer

BriaCell Reveals P-II Trial Data of Bria-IMT Regimen for Metastatic Breast Cancer

  • April 17, 2025
Telix Pharmaceuticals Reports Preliminary P-II (IPAX-Linz) Trial Data of TLX101 to Treat Glioma

Telix Pharmaceuticals Reports Preliminary P-II (IPAX-Linz) Trial Data of TLX101 to Treat Glioma

  • April 17, 2025
Eli Lilly Reports P-II (ALPACA) Trial Data of Lepodisiran for Heart Diseases

Eli Lilly Reports P-II (ALPACA) Trial Data of Lepodisiran for Heart Diseases

  • March 31, 2025
Crinetics Pharmaceuticals Reports the EMA’s Acceptance of Paltusotine for Acromegaly

Crinetics Pharmaceuticals Reports the EMA’s Acceptance of Paltusotine for Acromegaly

  • March 31, 2025
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2025 PharmaShots - All Rights Reserved.